Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Use of quinine and mortality-risk in patients with heart failure-a Danish nationwide observational study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Can we identify allergic rhinitis from administrative data: A validation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The impact of socioeconomic status on the risk of total hip arthroplasty during 1995 to 2017 in Denmark

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  4. All-cause mortality, suicide and self-harm in patients with treatment-resistant depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. GWAS of antidepressant treatment non-response in depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Researchers in cardiology - Why and how to get on Twitter?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Severity of anaemia and association with all-cause mortality in patients with medically managed left-sided endocarditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence of appendicitis during COVID-19 lockdown: A nationwide population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Leg cramps are common in patients with heart failure. Quinine is frequently prescribed in low doses to these patients, but safety of this practice is unknown. We studied the outcomes associated with use of quinine in a nationwide cohort of patients with heart failure.

METHODS: Through individual-level-linkage of Danish national registries, we identified patients discharged from first-time hospitalization for heart failure in 1997-2010. We estimated the risk of mortality associated with quinine treatment by time-dependent Poisson regression models.

RESULTS: A total of 135 529 patients were included, with 14 510 patients (11%) using quinine at some point. During a median time of follow-up of 989 days (interquartile range 350-2004) 88 878 patients (66%) died. Patients receiving quinine had slightly increased mortality risk, adjusted incidence rate ratio (IRR) 1.04 (95% confidence interval [CI] 1.01 to 1.07). The risks differed according to concomitant β-blocker treatment. For patients treated with both quinine and β-blockers IRR was 1.15 (95% CI 1.09 to 1.21) vs. 0.99 (95% CI 0.96 to 1.03) for patients treated with quinine but not β-blockers. The risks were highest shortly after initiation of therapy: for the first 14 days of treatment IRR was 2.12 (95% CI 1.54 to 2.93) for patients in treatment with β-blockers and 1.17 (95% CI 0.86 to 1.59) for patients not treated with β-blockers.

CONCLUSIONS: Use of quinine was common and associated with increased mortality in heart failure, especially if administered together with β-blockers and shortly after treatment initiation. Mechanisms underlying the findings remain to be established. Copyright © 2015 John Wiley & Sons, Ltd.

OriginalsprogEngelsk
TidsskriftPharmacoepidemiology and Drug Safety
Vol/bind24
Udgave nummer3
Sider (fra-til)310-8
ISSN1053-8569
DOI
StatusUdgivet - 4 feb. 2015

ID: 44982378